Mr Samer Jallad

Mr Samer Jallad

Urology 06082721

  • Fee assured
  • Open Referral network
Fee assured
Open Referral network

Specialises in

  • Benign Prostate disorders
  • Functional urology/continence
  • Urological oncology


  • Face-to-face consultations
  • Video and telephone consultations

About me

Mr Jallad is a consultant urological surgeon at Frimley Health NHS Foundation Trust working mainly at Heatherwood and Wexham Park Hospitals and covers St Mark’s Hospital at Maindenhead and King Edward VII at Windsor. In addition to general and common core urology, he has sub-specialist interest in the diagnosis and treatment of prostate hypertrophy and bladder outflow obstruction as well as specialist interest in the investigation of haematuria and the diagnosis and management of bladder cancer. He is also interested in adopting new technology and utilising minimally invasive surgery in the treatment of urological conditions including bladder cancer, bladder dysfunction, benign prostatic hypertrophy.

He qualified from medical school in 2003 with distinctions. He completed the higher specialist training in Urology at North-West Thames which included rotations at The Royal Marsden and Imperial College Healthcare.

He completed a Master’s degree from Cardiff University in advanced surgical practice and awarded a PhD in Urology from Brighton and Sussex Universities for his work in researching clinical and molecular biomarkers related to bladder cancer treatment. He is very passionate about research and academic work, presented in many national and international conferences and has many publications in peer-review journals.

Since the appointment as a consultant in Frimley Health, he introduced 2 new services including outpatient laser treatment for bladder cancer and rapid access lower urinary tract symptoms service for men, as well as investing in day-case bladder cancer surgery and reducing the need for post-operative hospital admissions by >50%, adopting narrow-band imaging and blue light cystoscopy for better diagnostic abilities. He was the winner of the Frimley Health CEO challenge for change in 2020.

Areas of interest

Haematuria (Blood in Urine) investigations; Bladder Preservation treatment strategies for Bladder Cancer; Surgery for Benign (Non-Cancerous); Prostate Hyperplasia (Enlargement); Bladder outflow obstruction surgery; Blue-light Cystoscopy; Intravesical Bladder Treatment Strategies for Bladder Cancer; Testis Cancer; Upper Tract Urothelial Cancer Diagnostics and Treatment; Circumcision and Penile Surgery; Scrotal Surgery and Vasectomy; Acute or Chronic Prostatitis (Prostate Inflammation); Urinary tract infections; Urinary tract stone treatment and prevention; Overactive bladder symptoms and incontinence diagnosis and treatment ; Raised PSA investigation and prostate cancer diagnosis.

Medical secretaries

Anaesthetists worked with

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • M4510

    Diagnostic endoscopic examination of bladder (flexible cystoscopy) including any biopsy - (5-50)

  • M4712

    Bladder instillation of pharmacologic agent (including cystoscopy) - (5-50)

  • M4210

    Endoscopic resection of lesion of bladder (including cystoscopy) - (1-5)

    Parkside Private Suite Wexham (1-5)

  • M6583

    Transperineal MRI - US fusion targeted prostate biopsy - (1-5)

  • M2930

    Removal of prosthesis from ureter (including cystoscopy) - (1-5)

  • M2920

    Endoscopic insertion/removal of prosthesis into ureter (including bilateral and cystoscopy, +/- pyelography) - (1-5)

    Parkside Private Suite Wexham (1-5)

  • Show All (8 )...
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.